NIDDK awards Extend Biosciences with a Phase I grant
Extend Biosciences was awarded a Phase I SBIR grant to advance their long-acting insulin molecule for the treatment of diabetes.
Extend Biosciences was awarded a Phase I SBIR grant to advance their long-acting insulin molecule for the treatment of diabetes.